| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2134920 | Experimental Hematology | 2010 | 13 Pages |
Abstract
Results suggest that HDCT applied to lymphoma patients damaged MSCs, which was demonstrated by their reduced clonogenic potential, doubling time, and cell expansion rates when compared to controls.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Karen de Lima Prata, Maristela Delgado Orellana, Gil Cunha De Santis, Simone Kashima, Aparecida Maria Fontes, Rita de Cássia Viu Carrara, Patricia Vianna Bonini Palma, Luciano Neder, Dimas Tadeu Covas,